The Ultimate Mitochondrial Matrix — SS-31 + MOTS-c + NAD+ & Advanced Tier
A comprehensive mitochondrial restoration protocol with two tiers. Foundation Tier: SS-31 (inner membrane repair), MOTS-c (biogenesis activation), NMN (NAD+ substrate), PQQ (PGC-1α stimulation). Advanced Tier adds Urolithin A (mitophagy) and Taurine (membrane stability). Designed for chronic fatigue, exercise performance decline, and mitochondrial age-related dysfunction.
Daily Schedule
Timing and dosage for each step
08:00 AM
20 mg
SS-31 subcutaneous injection. This is the foundation — repair existing mitochondrial membranes before stimulating biogenesis. 20mg/day or 0.25mg/kg body weight.
10:00 AM
10 mg
MOTS-c subcutaneous injection, 2 hours after SS-31. SS-31 first restores membrane structure; MOTS-c then activates AMPK to drive mitochondrial biogenesis. The sequence matters.
08:00 AM
500 mg
NMN 500mg orally with SS-31. Provides NAD+ substrate for the restored and newly generated mitochondria. A repaired ETC with abundant NAD+ maximises ATP production.
08:00 AM
20 mg
PQQ 20mg with breakfast. Stimulates PGC-1α, synergising with MOTS-c for mitochondrial biogenesis. Also acts as an antioxidant protecting newly formed mitochondria.
Morning
1 g
Advanced Tier. Urolithin A 500–1000mg oral (Mitopure preferred). Activates PINK1/Parkin mitophagy pathway — clears dysfunctional mitochondria so the pool is replenished with functional units.
Morning
4 g
Advanced Tier. Taurine 2–4g oral powder. Stabilises mitochondrial membrane potential, reduces ROS production, and maintains mitochondrial protein synthesis fidelity.
Protocol Overview
Mitochondrial dysfunction is a primary driver of fatigue, cognitive decline, and accelerated ageing. This protocol addresses it comprehensively across six complementary mechanisms, organised into two tiers.
Foundation Tier
The core four-compound stack targeting mitochondrial repair and biogenesis.
Layer 1 — SS-31: Repairs the inner mitochondrial membrane by binding cardiolipin, restoring cristae structure, and recovering electron transport chain efficiency. You cannot build on a broken foundation.
Layer 2 — MOTS-c: Activates AMPK signalling to drive mitochondrial biogenesis — the creation of new, healthy mitochondria. More mitochondria, with repaired structure.
Layer 3 — NMN: Provides NAD+ substrate. A restored electron transport chain with abundant NAD+ substrate produces maximum ATP output.
Layer 4 — PQQ: Activates PGC-1α independently of MOTS-c, providing additive biogenesis stimulation and antioxidant protection of newly formed mitochondria.
Why Sequencing Matters
The critical principle: repair before building. MOTS-c drives biogenesis — creating more mitochondria. But if the existing mitochondrial population is structurally compromised, new mitochondria inherit defective membrane characteristics. SS-31 must precede MOTS-c to establish a healthy mitochondrial template.
Hence the 2-hour gap: SS-31 at 8am, MOTS-c at 10am.
Advanced Tier
Once the Foundation Tier is established (4+ weeks), add these two compounds to address mitophagy and membrane stability.
Urolithin A — the only supplement with Phase 2 RCT data demonstrating enhanced mitophagy in humans (Andreux et al., Nature Metabolism, 2019). Urolithin A activates the PINK1/Parkin pathway, clearing dysfunctional mitochondria and allowing the pool to be replenished with functional units. 500–1000mg/day oral, Mitopure preferred.
Taurine — stabilises mitochondrial membrane potential, reduces mitochondrial ROS production, and maintains mitochondrial protein synthesis fidelity. Singh et al. (Science, 2023) identified taurine as a key longevity molecule with mitochondrial mechanisms. 2–4g/day oral powder.
Dosing Summary
| Compound | Dose | Timing | Route | Tier |
|---|---|---|---|---|
| SS-31 | 20mg/day | 08:00 AM | Subcutaneous injection | Foundation |
| MOTS-c | 10mg/week | 10:00 AM (2h after SS-31) | Subcutaneous injection | Foundation |
| NMN | 500mg/day | 08:00 AM | Oral | Foundation |
| PQQ | 20mg/day | 08:00 AM with breakfast | Oral | Foundation |
| Urolithin A | 500–1000mg/day | Morning | Oral (Mitopure preferred) | Advanced |
| Taurine | 2–4g/day | Morning | Oral powder | Advanced |
MOTS-c cycling: 8 weeks on, 4 weeks off.
Who This Protocol Is For
- Chronic fatigue syndrome / ME-CFS
- Post-viral fatigue (Long COVID mitochondrial dysfunction)
- Age-related exercise performance decline
- Mitochondrial myopathy (under physician supervision)
- Biohackers targeting cellular energy optimisation
Protocol Duration
Phase 1 (Weeks 1–4): Foundation Tier only — assess tolerance and subjective energy response Phase 2 (Weeks 5–8): Add Advanced Tier (Urolithin A + Taurine) if Foundation is well-tolerated Assessment: VO2max testing, subjective energy/fatigue scoring, CoQ10/lactate levels if available
Monitoring
Grip strength and VO2max (functional mitochondrial output), CoQ10 serum (mitochondrial health marker), lactate at rest (mitochondrial efficiency), and subjective energy levels on a consistent scale.
Supporting Interventions
- CoQ10 (ubiquinol) 200mg/day: electron transport chain cofactor
- Magnesium malate 400mg: ATP synthesis cofactor
- Cold exposure: activates PGC-1α independently
- Zone 2 training: primary stimulus for mitochondrial biogenesis
- Avoid alcohol: acute mitochondrial toxin
An Alternative Route
This protocol is built around repair — SS-31 first, then biogenesis and NAD+. If you already train and want a plan built around mitochondrial signalling instead, with exercise as the first layer and MOTS-c as an optional experimental one, see The Mito-Peptide Advanced Protocol. They are alternative routes; run one, not both.
Disclaimer
SS-31 and MOTS-c are research peptides. NMN, PQQ, Urolithin A, and Taurine are supplements. This protocol is for educational purposes only.